{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:05:30Z","timestamp":1773356730761,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jtho.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T18:48:20Z","timestamp":1503600500000},"page":"134-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung"],"prefix":"10.1016","volume":"13","author":[{"given":"Sinead A.","family":"Noonan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejas","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gentry G.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R.","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Bunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Doebele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Thomas","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna E.","family":"Bar\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Ross","family":"Camidge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2017.08.005_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in\u00a0normal and malignant tissues","volume":"9","author":"Hammarstr\u00f6m","year":"1999","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jtho.2017.08.005_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-94-017-7215-0_14","article-title":"The role of CA 125 as tumor marker: biochemical and clinical aspects","volume":"867","author":"Bottoni","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtho.2017.08.005_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-94-017-7215-0_3","article-title":"Use of biomarkers in screening for cancer","volume":"867","author":"Duffy","year":"2015","journal-title":"Adv\u00a0Exp Med Biol"},{"key":"10.1016\/j.jtho.2017.08.005_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/ejcts\/ezt424","article-title":"Significance of the\u00a0serum carcinoembryonic antigen level during the\u00a0follow-up of patients with completely resected non-small-cell lung cancer","volume":"45","author":"Ozeki","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2017.08.005_bib5","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in\u00a0gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.08.005_bib6","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","article-title":"American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer","volume":"25","author":"Harris","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.08.005_bib7","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.2014.59.4945","article-title":"Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule\u00a0in the United Kingdom Collaborative Trial of Ovarian\u00a0Cancer Screening","volume":"33","author":"Menon","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.08.005_bib8","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/ijc.29242","article-title":"A\u00a0preoperative serum signature of CEA+\/CA125+\/CA19-9\u2009\u2265\u20091000 U\/mL indicates poor outcome to pancreatectomy for pancreatic cancer","volume":"136","author":"Liu","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtho.2017.08.005_bib9","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1002\/cncr.27409","article-title":"Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer","volume":"118","author":"Doebele","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2017.08.005_bib10","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/JTO.0000000000000321","article-title":"Crizotinib effects on creatinine and non-creatinine-based measures of glomerular filtration rate","volume":"9","author":"Camidge","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.08.005_bib11","doi-asserted-by":"crossref","first-page":"e0146063","DOI":"10.1371\/journal.pone.0146063","article-title":"Serum biomarkers associated with clinicaloutcomes fail to predict brain metastases in patients with stage IV non-small cell lung cancers","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2017.08.005_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2011.12.440","article-title":"Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer","volume":"125","author":"Xu","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"suppl 10","key":"10.1016\/j.jtho.2017.08.005_bib13","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1097-0142(19951115)76:10+<2004::AID-CNCR2820761317>3.0.CO;2-G","article-title":"Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers","volume":"76","author":"Skates","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2017.08.005_bib14","unstructured":"Meier W, Baumgartner L, Stieber P, Hasholzner U, Fateh-Moghadam A. CA125 based diagnosis and therapy in\u00a0recurrent ovarian cancer. Anticancer Res. 17(4B):3019\u20133020."},{"key":"10.1016\/j.jtho.2017.08.005_bib15","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/JTO.0b013e3182745948","article-title":"Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer","volume":"7","author":"Weickhardt","year":"2012","journal-title":"J\u00a0Thorac Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417306809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417306809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T02:22:13Z","timestamp":1546309333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086417306809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1556086417306809"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2017.08.005","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}